A new literature review explores the emerging application of CAR-T cell therapy in treating people with Systemic Lupus ...

This study is being conducted to evaluate the safety, tolerability, and ability to manufacture Descartes-08, an investigational mRNA CAR-T cell therapy, in people living with moderate to severe ...

May 23, 2024 — Treatment ... fix a defect that causes lupus, and hope their discovery will offer effective long-term ... Incurable Autoimmune Disease Systemic Lupus Erythematosus (SLE): New ...

Living in areas with lower COI levels was associated with more severe disease presentation and poorer disease control among patients with cSLE.

The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...

Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE ... of damaged joints and possible clinical manifestations of treatment toxicity as a result of long disease duration.

Amgen today announced financial results for the first quarter of 2025. "Demand for our products was strong globally in the first quarter. Ongoing new product launches and successful Phase 3 trial ...

Chimeric antigen receptor (CAR) T-cell therapy, initially developed for the treatment of refractory haematological ... therapy demonstrated promising results in patients with systemic lupus ...

One type of lupus, discoid lupus erythematosus ... provider will help you determine the best treatment for discoid lupus. Some options may include topical corticosteroids or corticosteroid injections.

Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal of the American Society of ...

An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according ...